chr11-126304269-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_014026.6(DCPS):c.189C>T(p.Phe63=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.226 in 1,613,960 control chromosomes in the GnomAD database, including 48,037 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.21 ( 4265 hom., cov: 32)
Exomes 𝑓: 0.23 ( 43772 hom. )
Consequence
DCPS
NM_014026.6 synonymous
NM_014026.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.38
Genes affected
DCPS (HGNC:29812): (decapping enzyme, scavenger) This gene encodes a member of the histidine triad family of pyrophosphatases that removes short mRNA fragments containing the 5′ mRNA cap structure, which appear in the 3′ → 5′ mRNA decay pathway, following deadenylation and exosome-mediated turnover. This enzyme hydrolyzes the triphosphate linkage of the cap structure (7-methylguanosine nucleoside triphosphate) to yield 7-methylguanosine monophosphate and nucleoside diphosphate. It protects the cell from the potentially toxic accumulation of these short, capped mRNA fragments, and regulates the activity of other cap-binding proteins, which are inhibited by their accumulation. It also acts as a transcript-specific modulator of pre-mRNA splicing and microRNA turnover. [provided by RefSeq, Apr 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28).
BP6
Variant 11-126304269-C-T is Benign according to our data. Variant chr11-126304269-C-T is described in ClinVar as [Benign]. Clinvar id is 1229675.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.38 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.622 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DCPS | NM_014026.6 | c.189C>T | p.Phe63= | synonymous_variant | 1/6 | ENST00000263579.5 | |
DCPS | NM_001350236.2 | c.189C>T | p.Phe63= | synonymous_variant | 1/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DCPS | ENST00000263579.5 | c.189C>T | p.Phe63= | synonymous_variant | 1/6 | 1 | NM_014026.6 | P1 | |
TIRAP-AS1 | ENST00000524964.2 | n.55G>A | non_coding_transcript_exon_variant | 1/2 | 2 | ||||
TIRAP-AS1 | ENST00000691542.1 | n.53G>A | non_coding_transcript_exon_variant | 1/2 | |||||
TIRAP-AS1 | ENST00000693424.1 | n.31G>A | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.208 AC: 31669AN: 151996Hom.: 4263 Cov.: 32
GnomAD3 genomes
AF:
AC:
31669
AN:
151996
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.280 AC: 70120AN: 250174Hom.: 12330 AF XY: 0.276 AC XY: 37422AN XY: 135378
GnomAD3 exomes
AF:
AC:
70120
AN:
250174
Hom.:
AF XY:
AC XY:
37422
AN XY:
135378
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.228 AC: 333494AN: 1461844Hom.: 43772 Cov.: 35 AF XY: 0.230 AC XY: 167403AN XY: 727220
GnomAD4 exome
AF:
AC:
333494
AN:
1461844
Hom.:
Cov.:
35
AF XY:
AC XY:
167403
AN XY:
727220
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.208 AC: 31675AN: 152116Hom.: 4265 Cov.: 32 AF XY: 0.220 AC XY: 16334AN XY: 74366
GnomAD4 genome
AF:
AC:
31675
AN:
152116
Hom.:
Cov.:
32
AF XY:
AC XY:
16334
AN XY:
74366
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1531
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Al-Raqad syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 30, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 16, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at